ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,496.84
-0.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. CRISPR Therapeutics AG (CRSP)

  7. CRISPR Therapeutics AG (CRSP) News

CRSP

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics AG
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRSP
DateTimeSourceHeadlineSymbolCompany
05/31/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/31/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/31/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/30/20243:26PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/29/20247:00AMGlobeNewswire Inc.CRISPR Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CRSPCRISPR Therapeutics AG
05/24/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/23/20243:25PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
05/23/20247:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
05/23/20247:00AMGlobeNewswire Inc.CRISPR Therapeutics Strengthens Executive Leadership Team with Key AppointmentsNASDAQ:CRSPCRISPR Therapeutics AG
05/09/20247:30AMGlobeNewswire Inc.CRISPR Therapeutics to Present at the Bank of America Securities Health Care ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
05/08/20243:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRSPCRISPR Therapeutics AG
05/08/20243:00PMGlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
05/08/20246:00AMGlobeNewswire Inc.CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing ApproachNASDAQ:CRSPCRISPR Therapeutics AG
04/22/20243:30PMGlobeNewswire Inc.CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:CRSPCRISPR Therapeutics AG
04/03/20247:00AMGlobeNewswire Inc.CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
04/01/20247:00AMGlobeNewswire Inc.CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:CRSPCRISPR Therapeutics AG
03/13/20247:30AMGlobeNewswire Inc.CRISPR Therapeutics Proposes New Appointment to the Board of DirectorsNASDAQ:CRSPCRISPR Therapeutics AG
02/21/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
02/21/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
02/21/20246:50AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRSPCRISPR Therapeutics AG
02/21/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
02/21/20246:30AMGlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
02/16/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
02/15/20243:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
02/15/20247:30AMGlobeNewswire Inc.CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership SummitNASDAQ:CRSPCRISPR Therapeutics AG
02/13/20247:44AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRSPCRISPR Therapeutics AG
02/13/20247:30AMGlobeNewswire Inc.CRISPR Therapeutics Announces $280 Million Registered Direct OfferingNASDAQ:CRSPCRISPR Therapeutics AG
02/13/20245:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
02/13/20241:30AMGlobeNewswire Inc.European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)NASDAQ:CRSPCRISPR Therapeutics AG
 Showing the most relevant articles for your search:NASDAQ:CRSP

Your Recent History

USOTC
WTWGF
Westwing (CE)
USOTC
CVOSF
Coveo Solutions (PK)
NASDAQ
AAWMVXX
Gs Finance Corp Autocall...
NASDAQ
RPID
Rapid Micro Biosystems
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved